Stereotactic body radiotherapy for pancreatic cancer – A systematic review of prospective data

Documenti analoghi

• High local failure rates despite high margin‐negative resection rates in a cohort of borderline resectable and locally advanced pancreatic cancer patients treated with stereotactic body radiation therapy following multi‐agent chemotherapy
  di: Colin Hill, et al.
  Pubblicazione: (2022-04-01)
• Dose-escalated SBRT for borderline and locally advanced pancreatic cancer. Feasibility, safety and preliminary clinical results of a multicenter study
  di: B. Salas, et al.
  Pubblicazione: (2024-03-01)
• Role of stereotactic body radiation in the enhancement of the quality of life in locally advanced pancreatic adenocarcinoma: a systematic review
  di: Marlies Vornhülz, et al.
  Pubblicazione: (2022-06-01)
• Technical feasibility of online adaptive stereotactic treatments in the abdomen on a robotic radiosurgery system
  di: Maaike T.W. Milder, et al.
  Pubblicazione: (2022-07-01)
• Editorial: Neoadjuvant treatment for resectable and borderline resectable pancreatic cancer
  di: Marco Massani, et al.
  Pubblicazione: (2023-01-01)